Search

Recent guidance from the SEC provides greater flexibility and clarity for issuers in verifying accredited investor status under Rule 506(c).

February.19.2025

U.S. life sciences VC rebounded in 2024 with rising deal and exit value. Orrick’s Life Sciences Snapshot breaks down the key trends.

With the CFPB on pause for now, we explore key questions about how the consumer financial services regulatory landscape appears to be shifting.

As the CFPB undergoes significant transition, certain state financial regulators and attorneys general appear poised to step into the Bureau’s shoes.

California regulators are adopting stricter measures and proposing sweeping reforms and legislation that could impact utility-scale BESS development.

Companies that create or produce a generative AI system with more than 1 million monthly users face new contracting requirements.

Financial institutions that purchase mortgage loans in Maryland face a new requirement to obtain a state license.

December.20.2024

Healthtech Horizons: Navigating Regulation, Investment, and Strategy in a Transforming Market

The U.S. Court of Appeals for the Fifth Circuit vacated the SEC’s approval of Nasdaq’s board diversity rules.

California Gov. Gavin Newsom has vetoed SB 1047 – the controversial AI regulation bill that both chambers of the California legislature passed by ...

School district employees must avoid using public resources for campaigns, follow strict guidelines and comply with SB 1439 to prevent legal ...

The EU AI Act emerged after years of deliberation among legislators crafting the first law to regulate AI systems and general-purpose AI models.